glp-1 agonist gastric emptying Agonist-Induced Delayed – A Clinical Pharmacology Perspective GLP-1 Intolerance and Endoscopic Sleeve

Differences in the study populations, treatment duration and adherence to the different GLP-1RA regimens might have contributed to the variations observed

The enzyme dipeptidyl peptidase-4 (DPP-4) rapidly degrades circulating GLP-1, which is why pharmaceutical versions are chemically modified to resist this breakdown and maintain therapeutic levels for extended periods

[DOI] [PubMed] [Google Scholar] 19.Evolution of GLP1 Receptor Agonists for Diabetes Treatment

MacMahon Copas AN, McComish SF, Fletcher JM, Caldwell MA

Combining GLP 1 medications with these glucose lowering agents substantially increases hypoglycemia risk

The timing was not coincidental